129;B6-Tg(Atm-ERT2-LBD)G3Mpel/Cnrm
| Status | Under development - register interest |
| EMMA ID | EM:16174 |
| Citation information | RRID:IMSR_EM:16174 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | 129;B6-Tg(Atm-ERT2-LBD)G3Mpel/Cnrm |
| Alternative name | Atm TgERT2-LBD Atm+/+ |
| Strain type | Transgenic Strains |
| Allele/Transgene symbol | Atm TgERT2-LBD |
| Gene/Transgene symbol | Atm TgERT2-LBD |
Information from provider
| Provider | Manuela Pellegrini |
| Provider affiliation | IBBC-CNR |
| Genetic information | The ERT2-LBD fragment, from the pCre-ERT2 plasmid, was inserted into Atm BAC RP24 122F1026 by homologous recombination to obtain Atm-ERT2-LBD transgenic mice. |
| Phenotypic information | Homozygous:Atm wild-type and heterozygous knock-out mice are normal. Atm homozygous knock-out mice show immunodeficiency, weight loss, radio-sensibility, lymphoma predisposition, male and female sterility. In absence of tamoxifen administration, no specific phenotype of the Atm TgERT2-LBD transgene in Atm wild-type or knock-out background is observed. However as we reported in Di Siena et al. (2018; PubMed ID:29472706; doi:10.1038/s41419-018-0357-8), upon tamoxifen administration body weight, immunodeficiency, spermatogenesis and radio-resistance are recovered in transgenic mice on Atm knock-out background. After tamoxifen-induced restoration of Atm expression life span is doubled, mice are protected from thymoma and no cerebellar defects are observed. Atm signaling is also functional after DNA damage.Heterozygous:Atm wild-type and heterozygous knock-out mice are normal. Atm homozygous knock-out mice show immunodeficiency, weight loss, radio-sensibility, lymphoma predisposition, male and female sterility. In absence of tamoxifen administration, no specific phenotype of the Atm TgERT2-LBD transgene in Atm wild-type or knock-out background is observed. However as we reported in Di Siena et al. (2018; PubMed ID:29472706; doi:10.1038/s41419-018-0357-8), upon tamoxifen administration body weight, immunodeficiency, spermatogenesis and radio-resistance are recovered in transgenic mice on Atm knock-out background. After tamoxifen-induced restoration of Atm expression life span is doubled, mice are protected from thymoma and no cerebellar defects are observed. Atm signaling is also functional after DNA damage. |
| Breeding history | The final targeting vector was purified for pronuclear injection into C57BL/6 oocytes. Several transgenic founder lines were obtained and crossed to Atm+/- knock-out mice on 129/SvEv background in order to test restoration of Atm transgenic expression in the Atm wild-type, heterozygous or homozygous null background. The submitted Tg(Atm-ERT2-LBD) G3 line does not carry the Atm knock-out allele. |
| References |
|
| Homozygous fertile | yes |
| Homozygous viable | yes |
| Homozygous matings required | no |
| Immunocompromised | yes |
Information from EMMA
| Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Literature references
- Atm reactivation reverses ataxia telangiectasia phenotypes in vivo.;Di Siena Sara, Campolo Federica, Gimmelli Roberto, Di Pietro Chiara, Marazziti Daniela, Dolci Susanna, Lenzi Andrea, Nussenzweig Andre, Pellegrini Manuela, ;2018;Cell death & disease;9;314; 29472706
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).
